AI assistant
Sending…
Boundless Bio, Inc. — Director's Dealing 2024
Mar 29, 2024
34838_dirs_2024-03-29_ae49e793-ea79-4eb0-97c3-4fdd1ac46291.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Boundless Bio, Inc. (BOLD)
CIK: 0001782303
Period of Report: 2024-03-27
Reporting Person: Oien Jessica (N/A)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-03-27 | Stock Option | $16.00 | A | 16234 | Acquired | 2034-03-26 | Common Stock (16234) | Direct |
Footnotes
F1: The stock option vests in 48 substantially equal monthly installments beginning on April 27, 2024.
More from Boundless Bio, Inc.
Interim / Quarterly Report
2026
May 8
Report Publication Announcement
2026
May 8
Regulatory Filings
2026
Apr 13
Major Shareholding Notification
2026
Feb 17
Major Shareholding Notification
2026
Feb 5
Director's Dealing
2026
Jan 26
Director's Dealing
2026
Jan 26
Director's Dealing
2026
Jan 26
Director's Dealing
2026
Jan 26
Director's Dealing
2026
Jan 26